Novo Nordisk | NVO - Current Assets

Stock Price
41.19
Daily Change
2.66 6.90%
Monthly
13.32%
Yearly
-33.64%
Q2 Forecast
39.20

Novo Nordisk reported DKK25.71B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bausch Health Companies USD 6.16B 92M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Zoetis USD 6.77B 185M Dec/2025